TSRI Logo
Research Advances
Ways to Give
Planning Your Estate
Scripps Research Champions
Recognizing Our Donors
Community Health Education
Conferences, Lectures & Events
Contact Us
Search
TSRI Home
 
 

Alexander W. Dreyfoos:
"I was immediately impressed by the power of Scripps Research to attract great researchers, provide them with the stimulating environment of a beehive, not a bureaucracy, and give them the freedom and encouragement to pursue their work without interference."
 

Learn About Us

Scripps Research scientists have identified a small synthetic molecule that can control the fate of embryonic stem cells, turning mouse stem cells into heart muscle.

Scripps Research is an international leader in the application of biomedical research to develop life-saving drug and other therapies. >>>

  
  GIVE NOW  

Financial contributions for Scripps Research can be made by credit card online.

PROGRAMS & EVENTS

Frontiers in Science >>>

Lab Notes >>>
SUBSCRIBE TO E-NEWS

Subscribe to At the Forefront, Scripps Research's monthly e-newsletter for philanthropists.

E-mail this page to a friend
  BREAKING NEWS

Cancer:
Scripps Research scientists have produced a powerful immune response in mice by incorporating an unnatural amino acid into a target protein. This novel approach could prove useful in the development of new vaccines for cancer, infectious diseases, and other disorders.

Diabetes:
Scripps researchers have detailed the kinetic mechanism of a kinase linked to diabetes which makes further study of this enzyme highly relevant in terms of potential treatment development.

Alzheimer's:
Research from a Scripps Florida lab suggests that non-coding RNA could become a target for potential diagnostic and therapeutic development.